This is unlikely to represent a common cellular adaptation to enhance an IFN-induced antiviral response to EBV or other infectious agents, as it does not occur uniformly among EBV-positive BL cell lines, and such an antiviral response would likely be inconsistent with the high incidence of EBV infection associated with endemic BL. Here, IFNA1 is linked to Burkitt lymphoma.